Retsevmo

Medicinal product

(Invented) name

Retsevmo

Active substance (s)

Selperkatinibas

Strength

160 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01EX22, selpercatinib

Marketing authorisation holder

Eli Lilly Nederland B.V., Nyderlandai

Date of authorisation

2021-02-11

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Selperkatinibas	160 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117353	103454	1103454	lizdinė plokštelė	N30		Receptinis	EU/1/20/1527/021	Netiekiama	-	-	No	-	-
117354	103456	1103456	lizdinė plokštelė	N56		Receptinis	EU/1/20/1527/022	Netiekiama	-	-	No	-	-
117355	103457	1103457	lizdinė plokštelė	N60		Receptinis	EU/1/20/1527/023	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-02-11	Registruotas